NetworkNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Receives USPTO Allowance of Key Patent Covering DN-TNFa Platform Technology for Treating Cancer

INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its receipt of United States Patent and Trademark Office (“USPTO”) formal notice of allowance to Patent Application Serial No. 15/776,061. The patent, titled “CANCER PREVENTION AND THERAPY BY INHIBITING SOLUBLE TUMOR NUCROSIS FACTOR,” covers INmune’s INB03 Program that utilizes dominant negative TNFα (“DN-TNFα”) technology for treating cancer. “This is an important patent for INmune Bio, Inc. and provides exclusivity for use of our DN-TNFα technology for the treatment of cancer,” INmune Bio Assoc. General Counsel Joshua Schoonover said in the news release. “With the approval from the USPTO, and the positive indication of allowable subject matter in the international preliminary report on patentability for the corresponding international PCT patent application, published as WO/2017/106278, we expect this patent family should develop into global intellectual property rights.”

To view the full press release, visit http://nnw.fm/ULr9Z

About INmune Bio, Inc.

INmune Bio, Inc. is a clinical-stage immunology company developing therapies targeting the innate immune system to fight disease. INmune Bio is developing two product platforms, the DN-TNFα Platform and an Immune Priming Platform, as well as multiple products related to these platforms that reengineer the patient’s innate immune system’s response to disease. In addition to INB03, the DN-TNFα Platform includes XPRO1595, a DN-TNFα protein biologic that targets soluble TNFα (sTNFα) and may have many beneficial effects in patients with Alzheimer’s disease by decreasing neuroinflammation; and NeuLiv, also a DN-TNFα protein biologic that may enable targeting of the underlying cause of non-alcoholic steatohepatitis (NASH), to help stop the disease and allow the liver to heal. The Immune Priming Platform includes INKmune, which is a natural killer (NK) cell therapeutic that primes the patient’s NK cells to attack minimal residual disease, the remaining cancer cells that are difficult to detect, which often cause relapse. INmune Bio’s product platforms utilize a precision medicine approach for the treatment of a wide variety of hematologic malignancies, solid tumors and neurodegenerative diseases. For more information, visit the company’s website at www.INmuneBio.com.

NOTE TO INVESTORS: The latest news and updates relating to INMB are available in the company’s newsroom at http://nnw.fm/INMB

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Latest News

Former UConn coach Jim Calhoun earns 900th career win

Feb 22, 2020

WEST HARTFORD, Conn. — Jim Calhoun’s 900th win looked like so many others during a Hall of Fame coaching career. He stomped. He screamed. He slammed objects. The only real difference is the sideline he now controls. The longtime Connecticut coach added another milestone Friday night when the University of Saint Joseph beat Pratt Institute 105-61. Now in his second season coaching in Division III, Calhoun joined Mike Krzyzewski, Jim Boeheim and Bob Knight — all former rivals and national champions at college basketball’s highest level — as the only coaches to coach at least 10 seasons in Division I...

Cowboys to introduce McCarthy as club's 9th coach Wednesday

Feb 22, 2020

FRISCO, Texas — The Dallas Cowboys will introduce Mike McCarthy as the ninth coach in franchise history Wednesday. The club made the announcement Tuesday, a day after McCarthy reached agreement on a deal to replace Jason Garrett. It's the second coaching stop for the 56-year-old McCarthy, who won a Super Bowl and went to the playoffs nine times in 12-plus seasons with Green Bay. The Packers won the title at the home of the Cowboys nine years ago. They went to the NFC championship game four times under McCarthy, who is 125-77-2 in the regular season and 10-8 in the...

Ghana soccer association fires all coaches

Feb 22, 2020

ACCRA, Ghana — The Ghana soccer association has fired all its national team coaches in a drastic and unexpected move. That includes the coaches for the men's and women's senior national teams and all men's and women's youth teams. In all, nine coaches were removed. The Ghana Football Association said it “dissolved the technical teams of all national teams with immediate effect” and “extends its appreciation to all coaches and members of the respective national teams for their contributions.” The GFA gave no reason for the decision. The move means Kwesi Appiah has been fired as coach of the men's...

Ode to Sports: Pats & Nats, a roster from A(stros) to Z(ion)

Feb 22, 2020

A year now passes. How’d I know? Analytics guys told me so. They crunched the data. What’s it mean? Anyone’s guess: 2019. First Quarter ‘Bama toppled, it’s Clemson’s prize – White House visit, with burgers, fries. Fury nearing incoherence, Saints aghast: No interference? Super Bowl is kind of boring – Pats and Brady, not much scoring. Hall of Fame vote, Sandman enters. All Rivera, no dissenters. Osaka sure looks here to stay. Australia makes her resume. The neck, the back, the aching knees – Vonn calls it quits, hangs up her skis. Taking it to the hoop and hilt, James...

Blackhawks rally to beat Blue Jackets in shootout

Feb 22, 2020

COLUMBUS, Ohio — The Chicago Blackhawks won in a shootout, and the Columbus Blue Jackets may have lost something more valuable than the game: their starting goalie. Joonas Korpisalo had to leave the game with an injury after unsuccessfully trying to stop the first-round overtime shot from Jonathan Toews. Columbus backup Elvis Merzlikins entered the game cold and allowed the third-round shooter, Patrick Kane, to juke him and get one in on the net. Chicago goalie Robin Lehner then shut down Nathan Gerbe in the third round of the tie-breaker to preserve the Blackhawks' 3-2 win. There was no update...

Search

About Us

Next Sports Web is a distinct sports news site focusing on the other aspect of the sports world which are hardly mentioned or spoken about.

Contact us: sales@nextsportsweb.com